A Photoactivated Agent for Bonding Tissue Containing Type-I Collagen
University of Kansas
posted on 10/03/2005
A preliminary step in designing and synthesizing photoactivated compounds that could potentially be used as an alternative to sutures or staples in surgical wound closure of collagenous tissues.
Suggested Uses
Detailed Description
The present invention is a preliminary step in designing and synthesizing photoactivated compounds that could potentially be used as an alternative to sutures or staples in surgical wound closure of collagenous tissues. The agent has been shown to bond ex vivo tendon and corneal samples as well as solid gelatin strips with UV exposures and may be ideal for bonding tissues high in type I collagen. Bond tensile strengths for the corneal and tendon samples are low compared to sutures.
Advantages:
� A light-activated collagen bonding agent replacing suture in wound closure
� Faster wound healing time
� Areas of the wound are firmly held together thus avoiding weakened corneal structure and possible future would failure
File Number: 99KUMC219
Other Information: *State of Development* Available for exclusive and non-exclusive license *Testing* Extending and testing compounds
This innovation currently is not available for online licensing. Please contact Jim Baxendale at University of Kansas for more information.
Find more innovations
